KRYS vs BIIB: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Biogen Inc in 2026
KRYS
Krystal Biotech Inc
$270.00
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | KRYS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $7.87B | $25.88B | BIIB |
| P/E Ratio | 39.04 | 20.09 | BIIB |
| EPS (TTM) | $6.85 | $8.78 | BIIB |
| Revenue Growth | 0.2% | -0.1% | KRYS |
| Gross Margin | 94.1% | 78.9% | KRYS |
Analyze KRYS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or BIIB a better investment?
Comparing KRYS and BIIB: Krystal Biotech Inc has a market cap of $7.87B while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and BIIB?
KRYS (Krystal Biotech Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (20.1x vs 39.0x).
Which is growing faster: KRYS or BIIB?
KRYS has higher revenue growth at 0.2% vs -0.1% for BIIB.
Which company is more profitable: KRYS or BIIB?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 78.9% for BIIB.
Which is the larger company: KRYS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $7.87B for KRYS.
Should I buy KRYS or BIIB in 2026?
Both KRYS and BIIB have investment merit. KRYS trades at $270.00 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and BIIB stock?
Key differences: Market Cap ($7.87B vs $25.88B), P/E Ratio (39.0x vs 20.1x), Revenue Growth (0.2% vs -0.1%), Gross Margin (94.1% vs 78.9%).